TY - JOUR
T1 - Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events
AU - Del Prete, Gregory Q.
AU - Park, Haesun
AU - Fennessey, Christine M.
AU - Reid, Carolyn
AU - Lipkey, Leslie
AU - Newman, Laura
AU - Oswald, Kelli
AU - Kahl, Christoph
AU - Piatak, Michael
AU - Quiñones, Octavio A.
AU - Gregory Alvord, W.
AU - Smedley, Jeremy
AU - Estes, Jacob D.
AU - Lifson, Jeffrey D.
AU - Picker, Louis J.
AU - Keele, Brandon F.
PY - 2014/7
Y1 - 2014/7
N2 - Following mucosal human immunodeficiency virus type 1 transmission, systemic infection is established by one or only a few viral variants. Modeling single-variant, mucosal transmission in nonhuman primates using limiting-dose inoculations with a diverse simian immunodeficiency virus isolate stock may increase variability between animals since individual variants within the stock may have substantial functional differences. To decrease variability between animals while retaining the ability to enumerate transmitted/founder variants by sequence analysis, we modified the SIVmac239 clone to generate 10 unique clones that differ by two or three synonymous mutations (molecular tags). Transfection- and infection-derived virus stocks containing all 10 variants showed limited phenotypic differences in 9 of the 10 clones. Twenty-nine rhesus macaques were challenged intrarectally or intravenously with either a single dose or repeated, limiting doses of either stock. The proportion of each variant within each inoculum and in plasma from infected animals was determined by using a novel real-time single-genome amplification assay. Each animal was infected with one to five variants, the number correlating with the dose. Longitudinal sequence analysis revealed that the molecular tags are highly stable with no reversion to the parental sequence detected in >2 years of follow-up. Overall, the viral stocks are functional and mucosally transmissible and the number of variants is conveniently discernible by sequence analysis of a small amplicon. This approach should be useful for tracking individual infection events in preclinical vaccine evaluations, long-term viral reservoir establishment/clearance research, and transmission/early-event studies.
AB - Following mucosal human immunodeficiency virus type 1 transmission, systemic infection is established by one or only a few viral variants. Modeling single-variant, mucosal transmission in nonhuman primates using limiting-dose inoculations with a diverse simian immunodeficiency virus isolate stock may increase variability between animals since individual variants within the stock may have substantial functional differences. To decrease variability between animals while retaining the ability to enumerate transmitted/founder variants by sequence analysis, we modified the SIVmac239 clone to generate 10 unique clones that differ by two or three synonymous mutations (molecular tags). Transfection- and infection-derived virus stocks containing all 10 variants showed limited phenotypic differences in 9 of the 10 clones. Twenty-nine rhesus macaques were challenged intrarectally or intravenously with either a single dose or repeated, limiting doses of either stock. The proportion of each variant within each inoculum and in plasma from infected animals was determined by using a novel real-time single-genome amplification assay. Each animal was infected with one to five variants, the number correlating with the dose. Longitudinal sequence analysis revealed that the molecular tags are highly stable with no reversion to the parental sequence detected in >2 years of follow-up. Overall, the viral stocks are functional and mucosally transmissible and the number of variants is conveniently discernible by sequence analysis of a small amplicon. This approach should be useful for tracking individual infection events in preclinical vaccine evaluations, long-term viral reservoir establishment/clearance research, and transmission/early-event studies.
UR - http://www.scopus.com/inward/record.url?scp=84904693953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904693953&partnerID=8YFLogxK
U2 - 10.1128/JVI.01026-14
DO - 10.1128/JVI.01026-14
M3 - Article
C2 - 24807714
AN - SCOPUS:84904693953
SN - 0022-538X
VL - 88
SP - 8077
EP - 8090
JO - Journal of Virology
JF - Journal of Virology
IS - 14
ER -